Uncategorized

The FDA approved afamitresgene autoleucel, or afami-cel (Tecelra), as the first T-cell receptor therapy for cancer.

Adding MRI to digital mammography may prevent more cancer deaths, but it also could contribute to false-positive biopsies, according to a study published Aug. 25 in JAMA Internal Medicine.

President Joe Biden launched the Cancer Moonshot in 2016, when he was serving as vice president in the Obama administration. President Biden reignited the initiative in 2022, setting a goal to reduce the cancer death rate by 50% in the…

GLP-1s reduced mortality and complications from cardiovascular events, according to a study published Aug. 22 in Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics.

Cardiology leaders are familiar with the common challenges across healthcare with staffing, pay issues and patient access being among the most pressing. But recently leaders are highlighting other areas that are contributing to the complex network of challenges.

Leaders from two top-five cancer centers, as ranked by U.S. News & World Report, shared with Becker's challenges they are facing this year and how they plan to address them.

Coral Gables-based Baptist Health South Florida has named Jenny Waltzer as COO of Baptist Health Cancer Care.

High-poverty rural regions in the Southern U.S. have the highest cardiovascular disease-associated death rate, according to a report published Aug. 16 in the Journal of Rural Health. 

Catheter-based, radiofrequency renal denervation is a cost-effective solution for patients with hypertension, according to a study published Aug. 13 in the Journal of the Society for Cardiovascular Angiography & Interventions.

The FDA approved a label change for Abbott's HeartMate 3 heart pump, eliminating aspirin use from patient treatment plans.